To determine if R-RAS2 not only accumulates at membrane ridges in CBM-MBC21 cells but also it is in the active form in such locations, we transfected those breast cancer cells with a recently published FRET biosensor used to determine the activity of R-RAS2 in T cell and B cell lymphomas [64]. Here, RRAS2 is linked to breast carcinoma.